Our Litigators of the Week are Mike Morin and David Frazier of Latham & Watkins and William (Bill) Raich of Finnegan, Henderson, Farabow, Garrett & Dunner. They led a trial team that helped Sarepta Therapeutics emerge victorious as the counter-claimant in patent litigation against Nippon Shinyaku concerning treatment for Duchenne Muscular Dystrophy, a degenerative muscular disorder. After a one-week timed trial in Delaware federal court, jurors sided with Sarepta, finding the Nippon Shinyaku invalid, finding Sarepta’s patent valid and infringed and awarded Sarepta $115.2 million in damages.